Activation of the AhR pathway correlates with reduced levels of glucagon-like peptide-1 (GLP-1) and interleukin-22 (IL-22), subsequently influencing intestinal permeability and lipopolysaccharide levels in functional gastrointestinal disorders. Here, GCG is linked to digestive system disorder.